SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-16-127785
Filing Date
2016-06-16
Accepted
2016-06-16 16:28:56
Documents
5

Document Format Files

Seq Description Document Type Size
1 425 a16-13380_3425.htm 425 28939
2 GRAPHIC g133803bgi001.jpg GRAPHIC 3034
3 GRAPHIC g133803bgi002.gif GRAPHIC 2251
4 GRAPHIC g133803bgi003.jpg GRAPHIC 5433
5 GRAPHIC g133803bgi004.jpg GRAPHIC 3031
  Complete submission text file 0001104659-16-127785.txt   50250
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filed by) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-34921 | Film No.: 161717866
SIC: 2834 Pharmaceutical Preparations